INOVIO is focused on developing and commercializing DNA medicines to potentially help treat or protect people from infectious diseases, cancer, and diseases associated with HPV.
INOVIO’s DNA medicines in development are precisely designed DNA plasmids delivered through INOVIO’s proprietary investigational smart device directly into the body’s cells to produce an immune response to potentially help treat or prevent disease.
The potential advantages of INOVIO’s DNA medicine platform are how fast DNA medicines can be designed and manufactured; the stability of the products, which do not require freezing in storage and transport; and the immune response and tolerability that have been demonstrated in clinical trials.
© Copyright 2022 INOVIO Pharmaceuticals. All rights reserved.